grant

The population impact of human papillomavirus vaccination on circulating genotypes [ 2011 - 2013 ]

Also known as: Effectiveness of HPV vaccine in reduction of vaccine types circulating among young women

Funded by National Health and Medical Research Council
Managed by The University of Melbourne
Managed by University of Melbourne
Provided by   National Health and Medical Research Council

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1007685]

Researchers: Prof Sepehr Tabrizi (Principal investigator) ,  A/Pr Julia Brotherton ,  Dr Matthew Stevens ,  Prof Susan Rachel Skinner

Brief description Infection with human papillomavirus (HPV) is very common. Persistent infection can cause abnormal changes to cervical cells as found on Pap smears and if untreated, over time can develop into cervical cancer. Recently, a vaccine was introduced in Australia for women aged 12-26. To monitor the effectiveness of this vaccine, young women aged 18-22 will be asked to self-collect a sample for HPV detection which will determine if HPV types targeted by vaccine are reducing in prevalence.

Funding Amount $AUD 249,259.02

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Help

Related Organisations

Related People

Subjects
Health Information Systems (Incl. Surveillance) | Medical and Health Sciences | Public Health and Health Services | cervical cancer | cervical carcinoma | cervical precancer | genotype | high risk | human papillomavirus (HPV) | papillomavirus infection | persistence | vaccine efficacy | vaccines |
Identifiers
Viewed: [[ro.stat.viewed]]
Saved to MyRDA Save to MyRDA
ACN 633 798 857